Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1798 1
1801 1
1890 1
1893 1
1896 2
1898 1
1903 1
1906 2
1908 4
1910 3
1911 2
1912 1
1913 2
1914 5
1915 1
1916 4
1919 1
1920 4
1921 1
1922 6
1923 6
1924 1
1925 1
1926 10
1927 4
1928 3
1929 2
1931 4
1938 1
1940 3
1944 2
1945 3
1946 6
1947 2
1948 3
1950 1
1951 1
1952 2
1953 1
1954 1
1955 1
1956 1
1957 2
1958 7
1959 1
1960 3
1961 2
1962 3
1963 1
1964 2
1965 1
1966 4
1968 1
1969 2
1970 2
1971 1
1973 2
1974 2
1976 4
1977 5
1978 4
1979 5
1980 4
1981 9
1982 8
1983 4
1984 2
1985 7
1986 7
1987 9
1988 13
1989 11
1990 12
1991 12
1992 31
1993 22
1994 18
1995 17
1996 11
1997 21
1998 27
1999 29
2000 27
2001 30
2002 25
2003 28
2004 29
2005 28
2006 51
2007 58
2008 47
2009 49
2010 52
2011 92
2012 72
2013 78
2014 64
2015 84
2016 69
2017 68
2018 64
2019 59
2020 65
2021 78
2022 85
2023 69
2024 75
2025 73
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,802 results

Results by year

Filters applied: . Clear all
Page 1
Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. De Oliveira DMP, et al. Among authors: paterson dl. Clin Microbiol Rev. 2020 May 13;33(3):e00181-19. doi: 10.1128/CMR.00181-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32404435 Free PMC article. Review.
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. Among authors: paterson dl. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.
BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network; Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S, Hall R, Dwivedi DB, McArthur C, McGuinness S, Yahav D, Coburn B, Geagea A, Das P, Shin P, Detsky M, Morris A, Fralick M, Powis JE, Kandel C, Sligl W, Bagshaw SM, Singhal N, Belley-Cote E, Whitlock R, Khwaja K, Morpeth S, Kazemi A, Williams A, MacFadden DR, McIntyre L, Tsang J, Lamontagne F, Carignan A, Marshall J, Friedrich JO, Cirone R, Downing M, Graham C, Davis J, Duan E, Neary J, Evans G, Alraddadi B, Al Johani S, Martin C, Elsayed S, Ball I, Lauzier F, Turgeon A, Stelfox HT, Conly J, McDonald EG, Lee TC, Sullivan R, Grant J, Kagan I, Young P, Lawrence C, O'Callaghan K, Eustace M, Choong K, Aslanian P, Buehner U, Havey T, Binnie A, Prazak J, Reeve B, Litton E, Lother S, Kumar A, Zarychanski R, Hoffman T, Paterson D, Daley P, Commons RJ, Charbonney E, Nau… See abstract for full author list ➔ BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network, et al. Among authors: paterson d. N Engl J Med. 2025 Mar 13;392(11):1065-1078. doi: 10.1056/NEJMoa2404991. Epub 2024 Nov 20. N Engl J Med. 2025. PMID: 39565030 Clinical Trial.
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, Davis JS, Finfer S, Hammond NE, Knowles S, Liu X, McGuinness S, Mysore J, Paterson DL, Peake S, Rhodes A, Roberts JA, Roger C, Shirwadkar C, Starr T, Taylor C, Myburgh JA, Lipman J; BLING III Study Investigators. Dulhunty JM, et al. Among authors: paterson dl. JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779. JAMA. 2024. PMID: 38864155 Free PMC article. Clinical Trial.
Multidrug-Resistant Bacteria in the Community: An Update.
van Duin D, Paterson DL. van Duin D, et al. Among authors: paterson dl. Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30. Infect Dis Clin North Am. 2020. PMID: 33011046 Free PMC article. Review.
Achromobacter Infections and Treatment Options.
Isler B, Kidd TJ, Stewart AG, Harris P, Paterson DL. Isler B, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01025-20. doi: 10.1128/AAC.01025-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32816734 Free PMC article. Review.
Culture-independent detection systems for bloodstream infection.
Peri AM, Harris PNA, Paterson DL. Peri AM, et al. Among authors: paterson dl. Clin Microbiol Infect. 2022 Feb;28(2):195-201. doi: 10.1016/j.cmi.2021.09.039. Epub 2021 Oct 20. Clin Microbiol Infect. 2022. PMID: 34687856 Free article. Review.
Antibiotic therapy for severe bacterial infections.
Timsit JF, Ling L, de Montmollin E, Bracht H, Conway-Morris A, De Bus L, Falcone M, Harris PNA, Machado FR, Paiva JA, Paterson DL, Poulakou G, Roberts JA, Roger C, Shorr AF, Tabah A, Lipman J. Timsit JF, et al. Among authors: paterson dl. Intensive Care Med. 2025 Oct;51(10):1867-1885. doi: 10.1007/s00134-025-08063-0. Epub 2025 Sep 1. Intensive Care Med. 2025. PMID: 40888899 Review.
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Bassetti M, et al. Among authors: paterson dl. Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058795 Clinical Trial.
1,802 results